Gensco Laboratories LLC d/b/a Gensco Pharma, a leader in specialty pharmaceuticals, proudly announces the acquisition of the global rights and intellectual property for the first and only rizatriptan Oral Dissolvable Film (ODF), which was co-developed under the trade names RizaFilm in the U.S. and both RizaFilm and RizaPort globally.
Private research nonprofit BrightFocus Foundation announced nearly $13 million in grants to support early investigative research into Alzheimer’s disease, macular degeneration, and glaucoma. This includes $7.3 million to its Alzheimer’s Disease Research program, $3.8 million to its Macular Degeneration Research program, and $1.8 million to its National Glaucoma Research program.
Kincell Bio announced the completion of a $22 million round, led by a new investor, NewSpring Capital through its dedicated healthcare strategy, NewSpring Healthcare, which invests in innovative companies in the lower-middle market that improve the delivery of healthcare or bend the cost curve through technology and human capital efficiencies.
Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, announced the commercial availability of the SOFIA™ 88 Neurovascular Support Catheter, expanding the company's stroke portfolio with a new large-bore catheter engineered for reliability, procedural flexibility, and physician control. The launch builds on the proven clinical performance and global legacy of the SOFIA™ Catheter line, which has supported more than 500,000 procedures across 170 countries over the past decade.
Rockwell Automation, Inc., the world's largest company dedicated to industrial automation and digital transformation, announced the launch of FactoryTalk® PharmaSuite® 12.00. The latest release of its manufacturing execution system (MES) is designed to support the unique needs of regulated pharmaceutical and...
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, announced the appointment of the company’s co-founder and Chief Scientific Officer, Nate Fernhoff, Ph.D., as Chief Executive Officer (CEO), succeeding Ivan Dimov, Ph.D. In addition, co-founder and Chief Operating Officer, Jeroen Bekaert, Ph.D., has assumed the role of President.
Bruker Corporation announced the launch of the nVista 2P miniature, two-photon microscope, a groundbreaking addition to the Inscopix product line for functional imaging of freely behaving animals. It leverages advanced two-photon fluorescence microscopy technology to enable high-resolution imaging at greater depths with 3D data reconstruction, providing researchers with unprecedented insights into neuronal activity. Featuring several innovations in miniscope design, nVista 2P offers enhanced resolution for sub-cellular imaging and mapping of neural circuit dynamics.
AptarGroup, Inc. a global leader in drug and consumer product dosing, dispensing and protection technologies, announces the commencement of a clinical study to validate its proprietary SmartTrack™ platform.
Bruker Corporation announced a majority investment in RECIPE Chemicals + Instruments GmbH, based in Munich, Germany. RECIPE is a leading European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in vitro diagnostic kits for LC-MS/MS, HPLC, and ICP-MS assays.
Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, announces the positive results from the SPEED1 survey, showcasing the impact of the iPUMP® connected assistant on adherence to Stallergenes Greer’s sublingual liquid immunotherapy (SLIT).